Respira Health



STARTED: 2025 April
Co-founder
SEED GRANT: $110,000
CONTACT: oli@respirahealth.org | rowan@respirahealth.org
Co-founder
Closing the treatment gap for Chronic Obstructive Pulmonary Disease (COPD), the world's fourth deadliest disease.
DESCRIPTION OF THE INTERVENTION
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death worldwide. It’s a degenerative lung condition, primarily caused by smoking and air pollution, which leads to respiratory and heart failure. It kills more than 3 million people every year and 90% of these deaths are in low- and middle-income countries.
While pulmonary rehabilitation (PR) is a proven, cost-effective treatment, access in LMICs is severely limited due to healthcare workforce shortages and logistical barriers. Digital PR offers a breakthrough: the same life-extending care, accessible anytime, anywhere.
During the first year, Respira Health will be building and testing their digital solution. Their focus is on evaluating their current assumptions and building a model that they can scale in the following years.